Dr. Ali Chesney is a Scientist III with ToxStrategies in the Biopharmaceutical and Pharmaceutical Practice, based in Madison, Wisconsin. She oversees the study design, protocol development, study conduct, data interpretation, and report finalization of pharmacokinetic, pilot, and general toxicology studies (non-GLP and GLP) in a number of animal models. Her experience includes studies using rodents (mice, rats, and hamsters), rabbits, minipigs, canines, and nonhuman primates.
Dr. Chesney has served as a Study Director in a Contract Research Organization (CRO) in the US and China, where she directed nonclinical acute, short-term, sub-chronic, chronic, and carcinogenicity studies to assess the general toxicology of a variety of pharmaceutical, biological, and food product compounds in support of regulatory agency submissions. She was responsible for the technical conduct of nonclinical toxicology studies, as well as the study design, and interpretation, analysis, documentation, and reporting of results. She has experience developing protocols in compliance with appropriate SOPs, GLPs, and regulatory agency guidelines.
Dr. Chesney earned her Ph.D. in Molecular and Environmental Toxicology from the University of Wisconsin in Madison; her research focused on amplification and characterization of neuropathogenic proteins, the environmental and in vivo transmission of transmissible spongiform encephalopathies (prion diseases), and the inactivation of the prion disease agent. Dr. Chesney is a co-author of numerous meeting abstracts and peer-reviewed publications.